Tommie Reerink

Stock Analyst at Goldman Sachs

(1.39)
# 3,452
Out of 4,915 analysts
3
Total ratings
66.67%
Success rate
-4.76%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Tommie Reerink

Atara Biotherapeutics
Jul 17, 2024
Maintains: Sell
Price Target: $13$11
Current: $11.52
Upside: -4.51%